(Q36877213)

16 August 2017

1 reference

title

Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies (English)

1 reference

16 August 2017

0 references

1 reference

Gerald Friedland

1

1 reference

16 August 2017

Anthony Harries

series ordinal

2

1 reference

16 August 2017

David Coetzee

series ordinal

3

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

Journal of Infectious Diseases

16 August 2017

published in

1 reference

16 August 2017

volume

196 Suppl 1

1 reference

16 August 2017

page(s)

S114-23

1 reference

Implementing antiretroviral therapy in resource-constrained settings: opportunities and challenges in integrating HIV and tuberculosis care

16 August 2017

cites work

1 reference

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

21 January 2018

1 reference

BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005.

21 January 2018

1 reference

Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda

21 January 2018

1 reference

Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial

21 January 2018

1 reference

Preventing antiretroviral anarchy in sub-Saharan Africa

21 January 2018

1 reference

Monitoring the response to antiretroviral therapy in resource-poor settings: the Malawi model

21 January 2018

1 reference

Basing treatment on rights rather than ability to pay: 3 by 5.

21 January 2018

1 reference

Global health improvement and WHO: shaping the future

21 January 2018

1 reference

Tuberculosis in HIV-infected patients: a comprehensive review.

21 January 2018

1 reference

Integrating tuberculosis and HIV care in the primary care setting in South Africa

21 January 2018

1 reference

Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV.

21 January 2018

1 reference

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

21 January 2018

1 reference

HIV infection and multidrug-resistant tuberculosis: the perfect storm

21 January 2018

1 reference

Tuberculosis infection control in resource-limited settings in the era of expanding HIV care and treatment

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/518664

1 reference

16 August 2017

1 reference